Skip to main content

and
  1. Article

    Open Access

    Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis

    A plethora of second-line therapies have been recently introduced for hepatocellular carcinoma (HCC) treatment with promising results. A meta-analysis of second-line treatments for HCC has been performed to be...

    Antonio Giovanni Solimando, Nicola Susca in Clinical and Experimental Medicine (2022)

  2. No Access

    Article

    Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma?

    SBA classification is still based on the location of the primary tumor, without genetic information. in the current study, an extensive genetic profile of SBA, was performed in order to identify and quantify t...

    Andrea Casadei-Gardini, Sara Lonardi, Valeria Smiroldo, Matteo Canale in Medical Oncology (2021)

  3. No Access

    Chapter

    Hepatocellular Cancer

    Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer in adults, and currently it still remains third leading cause of cancer death.

    Riccardo Memeo, Patrick Pessaux, Nicola Silvestris in Practical Medical Oncology Textbook (2021)

  4. No Access

    Article

    Mast cells and angiogenesis in pancreatic ductal adenocarcinoma

    Mast cells are recognized as critical components of the tumor stromal microenvironment in several solid and hematological malignancies, promoting angiogenesis and tumor growth. A correlation between mast cell...

    Vito Longo, Roberto Tamma, Oronzo Brunetti in Clinical and Experimental Medicine (2018)